Does TENECTEPLASE Cause Haemorrhagic transformation stroke? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Haemorrhagic transformation stroke have been filed in association with TENECTEPLASE (TNKase). This represents 3.7% of all adverse event reports for TENECTEPLASE.
49
Reports of Haemorrhagic transformation stroke with TENECTEPLASE
3.7%
of all TENECTEPLASE reports
14
Deaths
19
Hospitalizations
How Dangerous Is Haemorrhagic transformation stroke From TENECTEPLASE?
Of the 49 reports, 14 (28.6%) resulted in death, 19 (38.8%) required hospitalization, and 8 (16.3%) were considered life-threatening.
Is Haemorrhagic transformation stroke Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENECTEPLASE. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does TENECTEPLASE Cause?
Off label use (430)
No adverse event (313)
Cerebral haemorrhage (132)
Angioedema (112)
Haemorrhage intracranial (74)
Haemorrhage (71)
Drug ineffective (68)
Death (60)
Cerebrovascular accident (45)
Subarachnoid haemorrhage (42)
What Other Drugs Cause Haemorrhagic transformation stroke?
ALTEPLASE (496)
RIVAROXABAN (257)
ASPIRIN (213)
DABIGATRAN ETEXILATE (113)
CLOPIDOGREL BISULFATE (85)
HEPARIN (47)
APIXABAN (41)
ENOXAPARIN (34)
ASPIRIN DL-LYSINE (33)
WARFARIN (28)
Which TENECTEPLASE Alternatives Have Lower Haemorrhagic transformation stroke Risk?
TENECTEPLASE vs TENELIGLIPTIN
TENECTEPLASE vs TENIPOSIDE
TENECTEPLASE vs TENOFOVIR
TENECTEPLASE vs TENOFOVIR ALAFENAMIDE
TENECTEPLASE vs TENOFOVIR DISOPROXIL